Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Aggressive B-Cell Non-Hodgkin Lymphoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
B-Cell Malignant Neoplasm
B-Cell Non-Hodgkin Lymphoma
Aggressive B-Cell Non-Hodgkin Lymphoma

Hematologic Malignancy

Aggressive B-Cell Non-Hodgkin Lymphoma

CI-CAN-00001751Explore in graph →

Hematologic115 active trials4 evidence items

NCIt: C178541

Overview
Statistics
Survival
Genomics7
Variants & evidence4
Drugs2
Trials400
Research
Rankings
Sources & provenance

Data completeness4 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A B-cell non-Hodgkin lymphoma with an aggressive clinical course. This category includes B lymphoblastic lymphoma, subtypes of diffuse large B-cell lymphoma, Burkitt lymphoma, grade 3 follicular lymphoma, and mantle cell lymphoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Aggressive Non-Hodgkin LymphomaHematologic Malignancy
B-Cell Non-Hodgkin LymphomaHematologic Malignancy

Children (9)

ncit

AIDS-Related Diffuse Large B-cell Lymphoma3 sub
B Lymphoblastic Lymphoma4 sub
Burkitt Lymphoma17 sub
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Diffuse Large B-Cell Lymphoma Unclassifiable2 sub
Grade 3 Follicular Lymphoma5 sub
Grade III Lymphomatoid Granulomatosis2 sub

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813

Record

Identity

CancerIndex ID: CI-CAN-00001751
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 5
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

Large B-Cell Lymphoma with 11q Aberration

Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

54 descendants in total; counters on this page aggregate over all of them.

400 / 115

Publications (all / 5y)

302 / 131

Evidence items

4

Genes / variants

144 / 4

Drugs (any / approved)

2 / 0

Genomic cohorts

7

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (0)

Only the preferred name is recorded so far.

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths19,882countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #8 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US new cases75,946countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #8 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US age-standardized mortality4.5per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #7 of 23 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
Active trials115countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #177 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials56countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #184 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items4countaccepted CIViC items · entity + descendantscivicComputedrank #276 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months36countPubMed records · stored query · 12-month windowpubmedComputedrank #556 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts7countopen GDC projects · entity + descendantsgdcComputedrank #124 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: cdc-uscs · latest year available per metric · counters aggregate over descendants